GlobeNewsWire
11 Nov 2026, 03:39 UTC · 13h ago
Neuronetics Announces Pricing of $30 Million Underwritten Public Offering of Common Stock
Impact · against what's priced in
Neuronetics' $30 million capital raise introduces immediate equity dilution through the issuance of 18.75 million shares. While the proceeds extend the cash runway into FY2027, the dilution effect typically outweighs the liquidity benefit for short-term price action.
- STIM−0.20
No priced-in read yet





